Abstract
We introduce the innovative use of technetium-99m–labeled macroaggregated albumin to diagnose high-output heart failure in a patient with multiple myeloma with persistent congestion symptoms. Symptom resolution occurred with lenalidomide and steroids. This marks the first clinical use of technetium-99m–labeled macroaggregated albumin for clarifying high-output heart failure etiology.
Original language | English (US) |
---|---|
Article number | 102387 |
Journal | JACC: Case Reports |
Volume | 29 |
Issue number | 14 |
DOIs | |
State | Published - Jul 17 2024 |
Keywords
- arteriovenous shunting
- high-output heart failure
- multiple myeloma
- technetium-99m-labeled macroaggregated albumin
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine